STUDY QUESTION: Does the molecular and metabolic profile of human mural granulosa cells (GCs) correlate with oocyte fate?
Introduction
In the clinical routine of ART, oocyte selection is mainly based on the morphological features of its cytoplasm, polar body and cumulus cells (CCs) (Balaban and Urman, 2006) . All these criteria for grading and screening oocytes are subjective and controversial, and seem not to be related to the intrinsic competence of the oocyte (Serhal et al., 1997; Balaban et al., 1998; Guerif et al., 2010; Ruvolo et al., 2013) . Moreover, the current knowledge of the mechanisms determining oocyte quality is still insufficient: what is known is that the relationship between the oocyte and its surrounding somatic cells is more complex than previously thought, and represents a determining factor for later developmental competence, crucial for the success of ART procedures (Suh et al., 2002) . In this light, the improvement of the oocyte quality assessment must be considered as critical to achieve higher success rates in ART. Helpful information can derive from the study of granulosa cells (GCs), which play a dominant role in regulating the development and competence acquisition of the oocyte and in maintaining the microenvironment as appropriate (Kidder and Vanderhyden, 2010) . In fact, it is well known that the process of acquisition of oocyte competence, defined as the ability of an oocyte to be fertilized and to develop to the blastocyst stage, strictly depends on the follicular microenvironment (Al-Edani et al., 2014) . All the processes involved in folliculogenesis heavily rely upon bi-directional interactions between germ cells and the surrounding GCs (Kidder and Vanderhyden, 2010) . GCs are known to support oocyte growth (Brower and Schultz, 1982) , control the advance of meiosis steps (Eppig, 1991) and regulate the oocyte transcriptional activity (De La Fuente and Eppig, 2001) . Furthermore, GCs carry out these important functions through the production of steroid hormones such as estradiol and progesterone (Canipari, 2000) , and of essential nutrients for oocyte development, modulating carbohydrate metabolism, and lipid synthesis, oxidation and storage in lipid droplets (Canipari, 2000; Chronowska, 2014) . Hence, oocyte quality is strongly related to GC functions, and the identification of specific molecular markers related to the activity of these cells could be potentially used to predict oocyte quality (Uyar et al., 2013) .
Fourier transform infrared microspectroscopy (FTIRM) is a wellestablished vibrational technique, widely applied to various biomedical fields in life sciences for diagnostic purposes (Baker et al., 2014) . The coupling of infrared (IR) spectroscopy with visible light microscopy offers the possibility to detect, at the same time and on the same sample, unique chemical and biological information about the composition and the structural building blocks of the sample (Matthäus et al., 2008; Movasaghi et al., 2008) . In fact, the analysis of FTIR spectral bands in terms of position, intensity and width, makes it possible to detect functional groups, bonding types and conformations of the most relevant biological molecules (proteins, lipids, sugars and nucleic acids) (Wolkers and Oldenhof, 2010) .
Several studies have been already carried out on the FTIR analysis of female gametes . In a previous work, we obtained, for the first time, the IR molecular fingerprint of human oocytes retrieved from patients of different age: alterations in plasma membrane, protein pattern, nucleic acids and metabolic processes were observed in oocytes from older patients . An attempt to correlate the metabolomic profile of spent culture media by near IR spectroscopy with embryo viability in frozenthawed embryo transfer cycles was also carried out (Vergouw et al., 2011) .
Considering the successful biomedical application of these spectroscopic techniques and the need for biological information not affected by the clinic environment and user manipulation, we performed, for the first time, the FTIRM analysis of human GCs. The study aimed to define the macromolecular and metabolic profile of single-follicle luteinized GCs; and retrospectively correlate these spectral data to the companion oocyte fate (in terms of clinical pregnancy (CP), fertilization failure (FF), embryo development failure (EDF) and implantation failure (IF)).
Materials and Methods
The study was approved by the Ethic Committee of 9.baby-Family and Fertility Center (Bologna, Italy) and was carried out in full accordance with ethical principles, including The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. Approval for the study was obtained from the local Institutional Review Board. Selected patients signed a written informed consent before participation to the study, which included the donation of GCs.
Patient selection
The study included 55 couples attending 9.baby-Family and Fertility Center (Bologna, Italy) for ART. Women were selected on the basis of the following inclusion/exclusion criteria: no smoking habit, age < 40 years, number of retrieved oocytes ≥8, diagnosis of tubal or idiopathic infertility, regular menstrual cycles (25-30 days) and FSH levels <10 IU/L on Day 3 of menstrual cycle. Male partners had a sperm total motile count after treatment ≥300.000/mL.
Ovarian stimulation protocol
Controlled ovarian stimulation (COS) was induced using a GnRH agonist (Enantone, Takeda, Rome, Italy) or an antagonist (Cetrotide, Serono, Rome, Italy; or Orgalutran, Organon, Rome, Italy) and recombinant or urinary FSH (Gonal-F, Serono, Rome, Italy or Meropur, Ferring, Milan, Italy, respectively). A dose of 10 000 IU hCG (Gonasi, Amsa, Rome, Italy) or one ampoule of recombinant hCG (Ovitrelle, Serono, Rome, Italy) was administered to achieve final oocyte maturation when one or few follicles reached a maximum diameter of >23 mm. Oocyte collection was performed transvaginally, under ultrasound guidance, 36 h after hCG injection.
GC sample collection
GCs were obtained from single-follicle aspirates of oocytes retrieved. Follicular fluid was centrifuged at 1100 g for 10 min room temperature. The supernatant was discarded and the pellet was dissolved in 2 mL of Sydney IVF Gamete Buffer Medium (Cook IVF, Brisbane, Australia) and overlaid on a 80-40% discontinuous gradient of silica particles suspension (1 mL PureSperm 40 and 1 mL PureSperm 80; Nidacon, Goteborg, Sweden) and centrifuged at 1600 g for 13 min at room temperature After centrifugation, three layers were observed: a top layer containing the follicular fluid, a middle ring-like layer containing GCs and a bottom layer containing erythrocytes. GCs were recovered from the middle ring-like layer using a Pasteur pipette and placed into 1 mL of NaCl 0.9% solution (Fresenius Kabi, Bad Homburg, Germany) . In the presence of contaminating red blood cells after initial isolation, a second step of gradient separation was repeated. Isolated GCs were centrifuged at 300 g for 10 min. The supernatant was discarded and the pellet re-suspended in 1 mL of NaCl 0.9% solution and washed again at 300 g for 10 min. After additional centrifugation for 5 min at 600 g, the cell pellet was re-suspended in 100 μL of sterile NaCl 0.9% solution. All centrifugations were carried out at room temperature.
Before IR measurements, all samples were first screened by transmitted light microscopy to verify possible gross contamination by CC. Moreover, in order to rule out the presence of residual CC in the samples, we performed the FTIRM characterization of both CCs and GCs, obtaining two very different and well discernable spectral profiles that were used to confirm the purity of the samples analysed in the study. Samples contaminated by CCs were discarded.
Oocytes culture, insemination, embryo culture and transfer Oocytes were collected, rinsed and placed individually in 50 μL drops of Sydney IVF Fertilization Medium (Cook IVF, Brisbane, Australia) at 37°C, 6% CO 2 , 5% O 2 e 89% N 2 until insemination. From this step on, every oocyte was cultured and handled singly until the embryo transfer to confirm its perfect correspondence with its own follicular fluid and in turn with its own GCs.
Semen preparation procedures and ICSI were carried out as previously described (Borini et al., 1996) .
Approximately 40 h after hCG administration, the oocytes were inseminated by standard IVF (22 patients) or ICSI (33 patients) technique.
At 16-18 h after insemination (Day 1), normal fertilization was assessed by observing the presence of two pronuclei and zygotes were placed in fresh Sydney IVF Cleavage Medium (Cook IVF, Brisbane, Australia). Embryo culture was carried out in an Embryoscope (UnisenseFertiliTech, Denmark), an integrated embryo-culture time-lapse microscopy system, in a N 2 /CO 2 /O 2 (89:6:5, v/v) atmosphere at 37°C without control of humidity. On Day 3, embryos were transferred into Sydney IVF Blastocyst Medium (Cook IVF, Brisbane, Australia) and cultured until Day 5 or Day 6. Transfer of a single blastocyst was performed on Day 5 or on Day 6. Blastocysts were evaluated on the basis of the degree of expansion, and quality of inner cell mass and trophectoderm cells, as described in the modified Gardner and Schoolcraft grading system by Cornell's group (Veeck and Zaninović, 2003) .
CP was confirmed by both high levels of hCG and ultrasound detection of a gestational sac.
Supernumerary blastocysts were individually cryopreserved using a vitrification protocol (Kitazato BioPharma Co, Japan) with a closed-system device (HSV straw, Cryo Bio System, France) as previously described (Cobo et al., 2008) .
Experimental design
In total, 284 GCs samples retrieved from the 55 enroled patients were retrospectively classified according to the corresponding oocyte clinical outcome into the following experimental groups:
FF: GCs from oocytes that failed to support a normal fertilization (N = 92).
EDF: GCs from oocytes developing into embryos that arrested during culture between Day 2 and the time of transfer (Day 5 or Day 6) (N = 113).
IF: GCs cell from oocytes developing into good quality embryos that failed to implant after transfer (N = 56).
CP: GCs from oocytes developing into good quality embryos that gave rise to a CP after transfer (N = 23).
The methodological process of the study is sketched in Fig. 1 . Pre-processing procedure of IR spectra
FTIRM data collection
All the absorbance IR spectra acquired were corrected for water vapour and CO 2 contributions by running the Atmospheric Compensation routine of OPUS software, and vector normalized in the entire spectral range, to mitigate for non-homogeneous thickness of samples (OPUS 7.1 software, Bruker Optics GmbH, Germany). Spectra were then cut in the spectral range 4000-1191 cm −1 owing to the possible presence, at lower wavenumbers, of bands related to contaminants used during the GC collection step.
To discard outliers, all the spectra acquired for each sample were analysed as follows. The areas of the 2990-2899 cm −1 and 1775-1191 cm −1 spectral intervals were calculated by drawing a straight line between the aforementioned wavenumber limits and integrating the area above this line (Integration Mode B, OPUS 7.1 software); their sum was defined as the overall cellular biomolecular content (Cell). For each GC sample, the mean of Cell ± SD was calculated, and all the spectra with values outside this range were discarded. Only those GC samples with at least 15 remaining spectra were further analysed.
IR data analysis
On each IR spectrum, specific bands of biological relevance were identified. For each of them, the corresponding spectral interval and the assignment to specific cellular functional groups were reported (Table I) . Then, for all these bands, the area integrals were obtained by using the aforementioned Integration Mode B and used to calculate specific band area ratios (Table II) .
Biomarker signature
For the biomarkers signature a balanced dataset, named DS1, was built. For this purpose, due to the different size of each experimental group (CP, N = 23; FF, N = 92; EDF, N = 113; IF, N = 56), not all the analysed GC samples were used; in particular, all the CP GCs (N = 23) were selected, while for FF, EDF and IF GCs, only 23 samples were randomly selected, respectively. The validation of this random selection was performed by exchanging, one by one, the samples included in the dataset with others belonging to the same experimental group (data not shown). Approximately, for each patient, two samples belonging to different experimental groups were chosen, for a total of 92 GC samples. DS1 was composed of 1043 rows, corresponding to the IR spectra of these selected GCs samples (290 for CP, 286 for FF, 200 for EDF and 267 for IF), and 19 columns corresponding to all the band area ratios calculated on these IR spectra and reported in Table II .
To identify the minimal subset of band area ratios (feature selection) necessary and non-redundant to segregate and characterize the experimental groups CP, FF, EDF and IF (defined as biomarker signature), the following statistical approaches were carried out on DS1 (XLSTAT 2017.01, Addinsoft, New York, NY, USA): 'Leave-one-out' method on FDA (Factorial Discriminant Analysis): FDA was performed by using all the band area ratios in DS1 and removing them one at a time, to evaluate their relevance in the definition of the experimental groups; Variable Characterization method: this method let us characterize the experimental groups, investigating the relations shared with the characterizing features: hence, it provides information on whether a feature is necessary or not to describe the experimental groups. To this end, a correlation coefficient is calculated between the categorical variable to characterize (experimental group) and the characterizing feature (band area ratio): if this coefficient is different from 0, a significant dependence exists between the categorical variable (experimental group) and the features (band area ratios). The statistical significance was determined by the Fisher F-test (P < 0.05); Logistic Regression method Figure 1 The methodological process followed in the study.
Granulosa cells (GCs) were collected from single-follicle aspirates and retrospectively classified according to companion oocyte clinical outcomes (CP, GCs from oocytes, which gave clinical pregnancy; FF, GCs from oocytes, which failed fertilization; EDF, GCs from oocytes, which failed embryo development, and IF, GCs from oocytes, which failed implantation). GCs samples were analysed by Fourier transform infrared microspectroscopy (FTIRM) and the obtained spectral data were then submitted to biomarker signature determination. The selected biomarkers were statistically validated and the macromolecular characterization of GCs was performed. FDA, factorial discriminant analysis; CAP, canonical analysis of principal co-ordinates; PERMANOVA, permutational multivariate ANOVA. with the Multinomial Logit model: this method was performed to link a set of selected features (band area ratios) with the probability of occurrence/ non-occurrence of an event (the probability that a GC sample belongs to one of the experimental groups), after classifying the features according to their importance and usefulness to distinguish the experimental groups. The null hypothesis (H0) was tested to define whether the variables (features) bring significant information: in particular, the Likelihood ratio test (−2 Log(Likelihood)), the Score test and the Wald test were performed comparing the model (built on the basis of DS1, composed of observations divided into experimental groups and features) with a simpler model composed of only one given constant. In addition, to determine whether all the selected features bring significant information, a further check was performed, running the Likelihood ratio test and removing one feature at a time: if Pr > LR (where Pr is the probability and LR is the likelihood ratio Chi square) is smaller than a selected significance threshold (P value 0.05), then the feature is necessary to describe the group.
Biomarker validation
To validate the selected biomarkers two multivariate statistical analyses were performed on a new dataset, named DS2, composed of 1043 rows, corresponding to the IR spectra on which band area ratios were calculated (290 for CP, 286 for FF, 200 for EDF and 267 for IF) and of 17 columns, corresponding to the 17 spectral biomarkers selected. In particular, permutational multivariate ANOVA (PERMANOVA) and FDA (Primer-E, Plymouth, UK) were carried out by using DS2. PERMANOVA is a distribution-and parameter-free multivariate analysis of variance, which uses permutations to estimate the statistical significance (PERMANOVA+ add-on package of the PRIMER-E software v. 6, Plymouth, UK). The data included in DS2 were normalized and organized in a Euclidean-distance matrix; the number of permutations was always set at 999. Statistical significance was set at 0.05 and was evaluated by the P value obtained by the permutation procedure for each term, named P(perm) (Anderson, 2001) , and by the Monte Carlo random draws from the asymptotic permutation distribution, named P(MC) (Anderson and Robinson, 2003) . A pair-wise PERMANOVA was also performed to carry out a one-to-one correlation of all the experimental groups. FDA enabled determination of which biomarkers were useful and necessary to discriminate GCs previously classified into the experimental groups (XLSTAT 2017.01, Addinsoft, New York, NY, USA). Statistical significance was set at P < 0.05. The null hypothesis (H0) that the within-class covariance matrices are equal was evaluated by the Box's test (carried out both with chi-square and Fisher's F asymptotic approximations) and the Kullback test. Wilks' Lambda test was also used to reject the null hypothesis that the mean vectors of the experimental groups are equal.
In addition, to further strengthen the validation of biomarkers previously selected canonical analysis of principal co-ordinates (CAP) was performed on a new dataset, named DS3. DS3 was built including only the average values of the biomarkers for each GC sample, hence composed as follows: n. 23 rows for CP, n. 23 rows for FF, n. 23 rows for EDF group and n. 23 for IF group, for a total of 92 rows and 17 columns, corresponding to the 17 spectral biomarkers selected. CAP is a constrained ordination method, which tests for significant differences among the a priori defined groups in multivariate space (PERMANOVA+ add-on package of the PRIMER-E software, v. 6, Plymouth, UK), finding the axes through the multivariate cloud of points, which best separate the a priori given groups (Anderson and Willis, 2003) . The data included in DS3 were normalized and organized in a Euclidean-distance matrix; the number of permutations was always set at 999. Pearson correlations were used to show linear relationships of spectral data with axes. The P value obtained using permutation procedures let us evaluate the a priori hypothesis of no difference within experimental groups. The value of the squared canonical correlation (δ_1 2 ) was used to assess the strength of the association between multivariate data and the hypothesis of group differences. A proper number of principal coordinates axes (m) was chosen automatically by the CAP routine. Lastly, a cross-validation procedure was performed for the chosen value of m (Anderson and Willis, 2003) .
Macromolecular characterization of GCs belonging to different experimental groups
The DS2 dataset was submitted to ANOVA followed by Dunnett's multiple comparisons test to better understand and highlight the macromolecular and metabolic pattern characterizing GCs belonging to each experimental group (OriginPro, version 9.4, OriginLab, Northampton, MA, USA). Statistical significance was set at P < 0.05.
Results
Single-follicle aspirate GCs, obtained with informed consent from 55 women undergoing a COS for IVF treatment, were analysed, for the first time, by using FTIR microspectroscopy. GC samples were retrospectively classified as CP, FF, EDF and IF.
On IR spectra of each GC sample, the following band area ratios were calculated and related to the concentration and structure of meaningful biomolecules contained in GCs (Tables I and II) .
Biomarker selection
The DS1 dataset, containing the 19 band area ratios calculated on all the IR spectra (N = 1043) acquired on GCs samples (N = 92), was used for the following feature selection procedures.
FDA was performed both on DS1, including all the 19 band area ratios (features), and on other 19 datasets, obtained by removing from DS1 one feature at a time. Supplementary Table SI reports the total percentages of correctness of the classification obtained by comparing the results from all datasets. The correctness percentage of the classification was increased when excluding PH1/LIP (phosphate1/lipids) and 1400/LIP. Conversely, for the remaining 17 investigated features, the total percentage of correctness was lower than the one achieved using all the band area ratios.
In the variable characterization method, the characterization of the categorical variable 'experimental group' was performed in order to elucidate the link it shared with the selected features (band area ratios). In this light, the correlation coefficient was calculated between the categorical variable and the characterizing feature, and then its value was analysed by Fisher F-test, in order to identify a possible dependence existing between the categorical variable (experimental group) and the features (band area ratios). For all the variables, the overall correlation coefficient was significantly different from 0, except for 1400/LIP (P = 0.243) and PH1/LIP (P = 0.367) (Supplementary Table SII) .
The logistic regression with multinomial logit model method was performed to classify the features according to their importance and usefulness for distinguishing the experimental groups. The null hypothesis (H0) was tested to define if all the features bring significant information, by the Likelihood ratio test (−2 Log(Likelihood)), the Score test and the Wald test: the model constructed on the basis of DS1 was compared with a simpler model composed of only one given constant (H0: Y = 0.274). Supplementary Table SIII reports the results of the three tests, in terms of probability of the Chi-square test (Pr > Chi 2 ) which is always lower than 0.0001, letting us conclude that significant information is provided by the variables, and the model based on DS1 is more robust than the one related to the null hypothesis. In addition, to determine whether all the selected features bring significant information, the Likelihood ratio test was performed removing one feature at a time: Pr > LR (where Pr is the probability and LR is the Likelihood Ratio Chi Square) checked for each feature, was smaller than 0.05. Hence, all the features, except for PH1/LIP and 1400/LIP, are necessary to describe the model (Supplementary Table SIV 
Biomarker validation
The PERMANOVA analysis indicated a strong discerning effect of the 17 selected biomarkers in the segregation of GCs samples from CP, FF, EDF and IF experimental groups (P(perm) = 0.001, P(MC) = 0.001) (Supplementary Table SV) . A pair-wise PERMANOVA was also performed to compare all pairs of experimental groups. Table III provides pair-wise post-hoc test results, which confirm a statistically significant discerning potential of the 17 selected biomarkers with respect to CP, FF, EDF and IF GCs.
The results obtained from the two Box's tests, carried out by using the chi-square asymptotic approximation and the Fisher's F asymptotic approximation, and by the Kullback test (Supplementary Table SVI) , confirmed the need to reject the hypothesis that the covariance matrices are equal among the groups.
The interpretation provided for the tests cited above, established that, as the computed P value is lower than 0.05, the null hypothesis H0 that the within-class covariance matrices are equal, should be rejected. F1 and F2 factors, with a cumulative discrimination percentage of 86.887, were used to perform FDA. The plot describing how the 17 selected biomarkers correlate with F1 and F2 factors is reported in Fig. 2A .
GC samples were classified by testing the posterior probability of the observations to belong to one of the experimental groups. The overall success of classification was of 80.25% (Table IV) ; in particular, the confusion matrix resulting from the analysis reporting the percentage of well characterized observations, showed that the best characterized group was EDF (88.50%), followed by FF (84.97%), IF (78.65%) and then CP (71.38%).
The percentages were obtained dividing the number of well classified observations by the total number of observations. Figure 2B shows the observations plotted on the factor axes.
CAP analysis was performed by using the DS3 dataset (see Materials and Methods). The plot obtained by CAP routine, showing the segregation of the four experimental groups and the Pearson correlations as vectors, is reported in Fig. 3 .
The cross-validation procedure assigned 69.565% of observations to CP, 73.913% to IF, 82.609% to FF and 91.304% to EDF, with a total correctness of 79.348% (Table V) .
Percentages of correctness were calculated dividing the number of well classified observations by the total number of observations. The very large (0.82259) first squared canonical correlation, the P value of 0.001, together with the high cross-validation allocation success, additionally indicate the significance of the 17 selected biomarkers in segregating GC samples in the experimental groups.
Macromolecular characterization of GCs from different experimental groups
DS2 was submitted to the ANOVA test for analysing the statistical variance of selected biomarkers among the experimental groups CP, FF, EDF and IF. The results are summarized in Fig. 4 . Each group was characterized by specific levels of band area ratios, representative of different biological and macromolecular traits. In particular, GCs from the CP experimental group showed lower values of the CH2/CH3 and CH2/LIP ratios ( Fig. 4L and M) , and higher values of the 1400/ 1460 ratio (Fig. 4H) , indicating a high amount of long chain fatty acids and of branched lipid chains. In FF GCs, higher values of LIP/CELL, CH/CELL, CH/LIP and CH/CH3 ratios (respectively, Fig. 4A, I , J and K) were found, representative of an increment of lipids with unsaturated alkyl chains. GCs from the EDF group showed higher values of PRT/CELL (Fig. 4B) and lower values of COO/CELL, COO/LIP and LIP/PRT (respectively, Fig. 4D , E and P), indicating lower amounts of lipids with respect to proteins; moreover, lower values of PH1/CELL and PH1/PRT (respectively, Fig. 4C and Q) were found suggesting a decrement of phosphate groups with respect to both the total cellular and protein amounts. IF GCs were mostly characterized by higher values of COO/CELL, COO/LIP and 1460/LIP (respectively, Fig. 4D , E and N), suggesting higher amounts of fatty acids; in addition, an increase of the 1400/PRT, 1460/PRT, AI/AII and LIP/PRT ratios (respectively, Fig. 4F , G, O and P) was detected, suggesting a lower amount of proteins with respect to lipid alkyl chains. Results reported as: t, pseudo-t, calculated as the square root of pseudo-F; P(perm), permutation P value; P(MC), Monte Carlo P-value. CP, Granulosa cells (GCs) from oocytes, which gave clinical pregnancy; FF, GCs from oocytes, which failed fertilization; EDF, GCs from oocytes, which failed embryo development, and IF, GCs from oocytes, which failed implantation.
Discussion
ART is a recognized medical practice leading to the birth of millions of babies, even if the success rate of such practice is still unsatisfactory (Tarín et al., 2014) . Furthermore, Patrizio and Sakkas (2009) stated that only~5% of fresh oocytes retrieved in ART leads to the birth of a baby, and it is still not known if the remaining 95% of retrieved oocytes reflects 'natural physiological waste' or if we are not able to correctly assess their quality. In recent years, several studies have been conducted on the CC and GC transcriptome, their metabolism and other functionalities, to identify molecular biomarkers of oocyte quality (Adriaenssens et al., 2010; Uyar et al., 2013; Kim et al., 2014; Dumesic et al., 2015; Borup et al., 2016; D'Aurora et al., 2016; Kordus and LaVoie, 2017) ; however, there is a lack of consensus on the achieved results (Uyar et al., 2013) .
In the present study, FTIRM was used for the first time, to characterize the vibrational fingerprint of GCs from single-follicle aspirates. GC samples were collected from patients selected on the basis of a The matrix reports the reclassification of the observations, and shows the percentage of well classified observations, calculated by dividing the number of well classified observations by the total number of observations. specific set of inclusion/exclusion criteria, to avoid biases related to age (Broekmans et al., 2009; Tatone and Amicarelli, 2013) , stimulation protocols (Hamamah et al., 2006; Adriaenssens et al., 2010; Haas et al., 2014) , smoking habits (Gannon et al., 2013; Sadeu and Foster, 2013) and infertility diagnosis (González-Fernández et al., 2010) . The spectral information from GCs was retrospectively related to the corresponding oocyte clinical outcome, in terms of CP, FF, EDF and IF, and 17 spectral biomarkers were selected. A strong discerning effect of these biomarkers was identified by PERMANOVA analysis, in terms of segregation of GCs samples into CP, FF, EDF or IF experimental group. In addition, the analysis of the FDA scores plot highlighted a clear separation of CP and IF GCs from FF and EDF GCs along F1 axis (62.75% of discrimination), and hence between GCs from oocytes that are able or not able to develop into embryos. Furthermore, the F2 axis (24.14% of discrimination) segregated CP from IF GCs, and hence embryos that resulted in a pregnancy from those that failed implantation. These results are not surprising, because the oocyte contribution is relevant but not exclusive considering also the role of the paternal contribution during the first stages of embryo development. Moreover, the embryo implantation capability depends not only on the embryo itself but also the endometrial receptivity of the patient.
The analysis of the plot describing how the 17 selected biomarkers correlate with F1 and F2 factors is consistent with the results from ANOVA for almost all the biomarkers. In particular, CP GCs were discriminated by the 1400/1460 ratio, COO/LIP, COO/CELL and 1460/PRT ratios were discriminant for IF GCs, while CH/LIP and CH/CELL segregated FF GCs; finally, EDF GCs were separated by PH1/PRT and PH1/CELL ratios. The confusion matrix reporting the percentage of well classified observations, confirmed that GCs from oocytes unable to develop into embryos (EDF and FF) were better characterized than those from oocytes able to give viable embryos (IF and CP).
Finally, the results obtained from CAP analysis were consistent with those obtained from FDA, demonstrating that the simplified dataset DS3 contains the fundamental information necessary for the correct classification of GCs into the four experimental groups.
Different biological characteristics of GCs belonging to different experimental groups were pinpointed by ANOVA analysis. Hence, these results confirm the close relation between oocyte fate and the follicular microenvironment (Dumesic et al., 2015) , and shed new light on the specific biochemical alterations in GCs and how they impact on the different clinical outcomes of their companion oocytes. In particular, FF seemed to be associated with an impairment in GC lipid metabolism, with higher amount of lipids and unsaturated alkyl chains. The matrix reports the leave-one-out allocation of observations to experimental groups, and shows the percentage of well classified observations, calculated by dividing the number of well classified observations by the total number of observations. Figure 4 Results of ANOVA test. Box charts show the values of the 17 biomarkers for each experimental group: centre line marks the median, edges indicate the 25th and 75th percentile, whiskers indicate the 5th and the 95th percentile, the black square marks the mean, black circles indicate the minimum and maximum values, coloured diamonds indicate the outliers. Different letters above box charts indicate a statistically significant difference among groups. Statistical significance was set at 0.05, and calculated by ANOVA followed by Dunnett's multiple comparisons test.
oxidation and storage in lipid droplets, is a crucial factor for correct follicle development (Gilchrist et al., 2008) . The utilization of triglycerides and fatty acids for metabolic needs relies on the lipolysis of triacylglycerol within lipid droplets, necessary for oocyte development (Dunning et al., 2014) . Hence, our results suggest that GCs with an impaired lipid metabolism could impair lipid storage of the surrounding oocyte thereby reducing its ability to be fertilized. In addition, GCs play a crucial role in regulating the pattern protein phosphorylation in the oocyte, as proved by culturing oocytes with or without follicular cells (Colonna et al., 1989; Cecconi et al., 1991) . The alteration in protein metabolism and the decrease in terms of phosphate groups in GCs belonging to the EDF experimental group shown in this study, could suggest an alteration of phosphorylated protein supply to the oocyte, resulting in a reduced ability of the oocyte to correctly develop into embryo. A concomitant alteration in both lipid and protein metabolism characterized by an increment of fatty acids and lower amount of proteins, as found in GCs from the IF experimental group, could be related to an impairment in the capability of the oocyte to develop into an embryo that can implant properly. Finally, from results concerning GCs belonging to CP experimental group, it is evident that not only the correct amount of macromolecules supplied by the GCs but also the quality (long chain fatty acid) could make the difference for the fate of the surrounded oocyte.
All these results demonstrate that GCs belonging to different experimental groups are characterized by specific macromolecular traits, ascribable to different biological and metabolic features. Moreover, these metabolic differences of GCs are strictly correlated to the companion oocyte fate and not to patient characteristics, and hence may explain why oocytes retrieved from the same patient undergo different fates.
To conclude, this is a proof-of-concept study suggesting the potential of FTIRM to identify biochemical differences in human GCs associated with oocytes with different developmental destinies. As such, in the first place this initial finding should be validated with larger groups of samples obtained from patients selected according to the same selection criteria. Then the applicability of the identified biomarkers should be verified for samples derived from other patient typologies, to assess the universality of the methodology. Ultimately, the clinical relevance of the proposed approach should be tested in a RCT, before introduction into clinical practice (Harper et al., 2012) . Regardless, the identified and validated biomarkers could be the basis for the development of a data standardization system based on machine learning techniques, with the final step of establishing a reliable, non-invasive and objective tool to predict oocyte fate by analysing the vibrational fingerprint of the surrounding GCs. Analysis of follicle cells as an approach to oocyte assessment and selection, such as that illustrated in the present study, has considerable potential advantages over more established embryo selection tools, for example preimplantation genetic testing (PGT). In fact, while PGT is technically highly developed and widespread, it requires removal of 1-2 blastomeres at the cleavage stage or 3-10 cells from the trophectoderm of the blastocyst. It has been shown that subtraction of such material is significantly detrimental to embryo viability at the cleavage stage. Concerns are also growing on the possibility that embryo biopsy can affect the implantation potential of the blastocyst. On the contrary, methodologies based on follicle cells analysis are totally non-invasive by definition and therefore promise to bring about a leap in the quest for safe and efficient oocyte/embryo selection. It is important to note, however, that any possible gamete/embryo selection tool, even if developed to a high level, can only improve treatment efficiency, i.e. reduce the effort (e.g. time to pregnancy or the number of attempts in a time interval) required to achieve a viable pregnancy. In contrast, increments in treatment efficacy (e.g. overall rate of success) will require more innovative, and difficult to develop, approaches to improvement of gamete or embryo quality.
